Cite
HARVARD Citation
Pollock, A. et al. (n.d.). 1 COVID-19 and QTc: is hydroxychloroquine worth the risk? A review of QT prolongation in hospitalised COVID-19 patients treated with hydroxychloroquine and azithromycin. Heart. p. A1. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Pollock, A. et al. (n.d.). 1 COVID-19 and QTc: is hydroxychloroquine worth the risk? A review of QT prolongation in hospitalised COVID-19 patients treated with hydroxychloroquine and azithromycin. Heart. p. A1. [Online].